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hESCThe ﬁrst stages of embryonic differentiation are driven by signaling pathways hardwired to induce particular
fates. Endoderm commitment is controlled by the TGF-β superfamily member, Nodal, which utilizes the
transcription factors, SMAD2/3, SMAD4 and FOXH1, to drive target gene expression. While the role of Nodal is
well deﬁned within the context of endoderm commitment, mechanistically it is unknown how this signal
interacts with chromatin on a genome wide scale to trigger downstream responses. To elucidate the Nodal
transcriptional network that governs endoderm formation, we used ChIP-seq to identify genomic targets for
SMAD2/3, SMAD3, SMAD4, FOXH1 and the active and repressive chromatin marks, H3K4me3 and H3K27me3,
in human embryonic stem cells (hESCs) and derived endoderm. We demonstrate that while SMAD2/3,
SMAD4 and FOXH1 associate with DNA in a highly dynamic fashion, there is an optimal bivalent signature at
32 gene loci for driving endoderm commitment. Initially, this signature is marked by both H3K4me3 and
H3K27me3 as a very broad bivalent domain in hESCs. Within the ﬁrst 24 h, SMAD2/3 accumulation coincides
with H3K27me3 reduction so that these loci become monovalent marked by H3K4me3. JMJD3, a histone
demethylase, is simultaneously recruited to these promoters, suggesting a conservation of mechanism at
multiple promoters genome-wide. The correlation between SMAD2/3 binding, monovalent formation and
transcriptional activation suggests a mechanism by which SMAD proteins coordinate with chromatin at
critical promoters to drive endoderm speciﬁcation.Stanford University, Stanford,
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Specialized signaling pathways drive the differentiation of human
embryonic stem cells (hESCs) toward speciﬁc cell fates, but how these
signaling networks cooperate with chromatin state has not been
extensively investigated. hESCs have highly euchromatic chromatin
and, upon differentiation, heterochromatic regions begin accumulat-
ing (Meshorer and Misteli, 2006). Within this euchromatic signature,
hESCs have a prevalent histone signature, called a bivalent domain,
where promoters are associated with both active (H3K4me3) and
repressive (H3K27me3) histone marks (Bernstein et al., 2006; Ku et
al., 2008). A particular bivalent conformation, with broad marks of
both H3K4me3 and H3K27me3 across promoters, exhibits a signiﬁ-
cant association with the promoters of developmentally regulated
genes. This bivalent domain in hESCs has been hypothesized to ‘poise’
developmental genes for rapid activation (Bernstein et al., 2006).Indeed, several reports have shown that bivalent domains are
resolved into either repressive (H3K27me3) or active (H3K4me3)
states upon differentiation, suggesting that cell fate commitment may
require the release of this primed bivalent state (Bernstein et al.,
2006; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007). While
hESCs harbor a signiﬁcant number of bivalent domains at develop-
mental promoters, this chromatin conformation exists to a lesser
degree in more differentiated cell types as well, including mouse
embryonic ﬁbroblasts (MEFs), neural progenitor cells (NPCs) and T
cells, suggesting that these domains continue to mark promoters for
further functional and rapid activation (Bernstein et al., 2006; Cui et
al., 2009; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et al., 2007).
While the bivalent domain is hypothesized to allow rapid activation of
molecules critical to guiding speciﬁc differentiation events, there is
very little molecular or biological evidence that supports this general
hypothesis, other than the important biochemical observation
describing this interesting domain. Signaling molecules must play a
role – either actively or passively – in the depletion of the repressive
mark, H3K27me3, and the accumulation of the active mark, H3K4me3,
at these speciﬁc developmentally important regions. It is imperative
that the interplay between these marks and speciﬁc transcription
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differentiation from pluripotency to a more differentiated state.
Endoderm is one of the ﬁrst cell types to emerge during embryogen-
esis and does so under the control of the Nodal signaling pathway. hESCs
can be driven toward endodermal fates by activation of the Nodal
signaling pathway, which utilizes serine threonine kinase receptors to
phosphorylate the intracellular proteins SMAD2 and SMAD3 (Attisano
and Wrana, 2000; Schier, 2003; Shen, 2007). These proteins translocate
into the nucleus and form an association with FOXH1 at regions within
the genome. Several direct targets of SMAD2/3/4 and FOXH1 have been
elucidated, including GSC, PITX2, LEFTY1, LEFTY2, NODAL and CADHERIN
(Izzi et al., 2007; Saijoh et al., 2003; Shiratori et al., 2001; Takaoka et al.,
2006; von Both et al., 2004). Genome-wide analysis of EOMES suggests
that it is a key regulator of SMAD2/3 at overlapping promoters leading to
the initial phases of endoderm formation (Teo et al., 2011). However,
little is known regarding how the SMAD2/3/4 and FOXH1 complex
assembles at speciﬁc genomic regions in a cell type speciﬁc manner.
Much less is known about how this complex interacts with chromatin to
release a repressive state. Recently, a mechanism has been proposed:
Dahle et al. (2010)demonstrated that SMAD2/3was capable of recruiting
the histone demethylase, JMJD3, to the NODAL promoter in mouse ESCs,
causing the loss of the repressivemarkH3K27me3. This strongly suggests
that a SMAD2/3/JMJD3 complex acts directly on the repressive chromatin
state, leading to transcriptional activation.
Nodal signaling is also required for self-renewal in hESCs (Besser,
2004; James et al., 2005; Vallier et al., 2005, 2009; Xu et al., 2008)
which appears contradictory as it is also involved in the ﬁrst stages of
endoderm commitment (D'Amour et al., 2005, 2006). As Nodal has
strong dose-dependent effects on cell fate speciﬁcation, it is likely that
the decision between maintaining pluripotency versus differentiation
is due to signiﬁcant changes in downstream effects in response to
varying levels of Nodal signaling. The effect of Nodal in self-renewal
may also be dependent upon the distinct chromatin state existing in
hESCs, including open chromatin and large array of bivalent domains
(Bernstein et al., 2006; Ku et al., 2008; Meshorer and Misteli, 2006).
To examine how Nodal signaling interacts and effects particular
chromatin states during hESC self renewal and endoderm commit-
ment, we used ChIP-seq to generate genome-wide target maps for
Nodal downstream transcription factors, including SMAD2/3, SMAD3,
SMAD4, FOXH1 and the chromatin marks, H3K4me3 and H3K27me3,
in hESCs and derived endoderm (D'Amour et al., 2005, 2006).
Interestingly, we ﬁnd that endoderm derived from hESCs has a
wider array of bivalent domain structures than hESCs. At promoters of
genes critical for differentiation, we observe a signiﬁcant depletion of
H3K27me3 only with a speciﬁc bivalent context. These ‘resolving’
bivalent domains are highly correlated with SMAD2/3 binding. We
further show that the resolution of these regions occurs together with
SMAD2/3 accumulation within the ﬁrst 24 h of differentiation and are
associated with JMJD3. This suggests that the resolution of the
bivalent domain is not a cause or effect of SMAD2/3 binding, but a
cooperative association between the transcription factor and chro-
matin context.
Material and methods
ChIP
ChIP was performed as previously described (Johnson et al., 2007).
5×106 cells were used for each ChIP. Cells were cross-linked with 1%
formaldehyde for 15 min at room temperature and the cross-linking
was stopped by adding Glycine (to be 125 mM) for 5 min. The cross-
linked cells were lysed in 500 μl of lysis buffer (50 mM Tris pH8.1,
10 mM EDTA, 1% SDS) with protease inhibitor cocktail (Roche). After
being diluted in 1.5 ml of IP buffer (25 mM Tris pH 8.0, 150 mM NaCl,
0.01% SDS, 0.5% Deoxycholate, 1% TritonX-100, 5 mM EDTA), the cell
lysatewas sonicated to generate 200- to 600-bp fragments. Fragmentedchromatin was immunoprecipitated withmagnetic beads coupled with
5 μg of each antibody. The antibodies usedwere anti-SMAD2/3 (A; Santa
Cruz, sc-8332, B; R&D Systems, AF3797), anti-SMAD3 (Abcam,
ab28379), anti-SMAD4 (R&D Systems, AF2097), anti-FOXH1 (R&D
Systems, AF4248), anti-JMJD3 (Abgent, AP1022a), anti-H3K4me3
(Abcam, ab8580) and anti-H3K27me3 antibody (Upstate, 07–449).
The pulldowned beads with immune complexes were washed twice
each with low salt buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.1% SDS,
0.5% Deoxycholate, 1% NP40, 1 mM EDTA), high salt buffer (50 mMTris
pH 8.0, 500 mM NaCl, 0.1% SDS, 0.5% Deoxycholate, 1% NP40, 1 mM
EDTA), LiCl wash buffer (50 mM Tris pH 8.0, 250 mM LiCl, 0.5%
Deoxycholate, 1% NP40, 1 mM EDTA) and Tris-EDTA buffer (10 mM
Tris pH 8.0, 1 mM EDTA) for 10 min at 4 °C. Immune complexes were
eluted in elution buffer (1% SDS, 0.1 M NaHCO3) for 1 h at 65 °C and
reverse cross-linked for 6 h at 65 °C. For sequential ChIP, the immune
complexes from the ﬁrst pulldownwere eluted in the elution buffer for
1.5 h at 37 °C. After diluted in IP buffer, the complexes were
immunoprecipitated with beads coupled with second antibody, and
washed and eluted again in the elution buffer for 1 h at 65 °C. Reverse
cross-linked DNA was puriﬁed by phenol/chloroform extraction and
further by QIAquick PCR puriﬁcation kit (Qiagen) and an aliquot was
used for PCR validation.We performed these ChIPs at least six times for
each of the antibodies and the qPCR levels had to be above 10× enriched
above input control in eachof the six replicates in order tomove forward
with making a sequencing library.
Sequencing and data processing
Sequencing libraries were prepared using Genomic DNA Sample
Kit (Illumina) according to the manufacturer's protocol. The ChIP-seq
libraries were sequenced by Genome Analyzer II (Illumina). Reads
were 36 bp, and we used Eland to map the ﬁrst 25 bp to human
genome assembly hg18 and mismatches up to 3 bp were allowed.
Only uniquelymapping readswere kept. Shifts were calculatedwithin
the peak calling programs QuEST 2.4 (Valouev et al., 2008) and
CisGenome (Ji et al., 2008). The negative control for sequencing was
the Input control library.
Transcription factor ChIP-seq readswere processed to call peaks using
CisGenome. The setting for peak-calling and sliding window size was
300 bp and the threshold number of reads required for peak to be called
was 11 reads. The false discovery rate allowed was 0.01. The resulting
peaks were mapped to the human genome hg18 to identify the locations
and numbers of peaks around annotated genes. Histone H3K4me3 and
H3K27me3 peaks were called using QuEST 2.4. We used the “histone”
bandwidth setting with “relaxed” peak-calling parameters.
Transcription factor binding regions and associated genes
We parsed the peaks to determine distributions across the gene
body. UCSC Known Genes (Human browser hg18) were used to locate
the peaks into annotated genomic regions, exon, intron, promoter
(±10 kb from transcription start site (TSS)) or intergenic region. We
then associated genes for each peak and the nearest genes within
1 Mb, 100 kb, 10 kb and 1 kb from TSS were counted. If additional
genes were within 25% of the distance to the closest genes, they were
also associated with the binding site. Further, we examined the
numbers of genes lying within the binding sites between hESCs and
endoderm within the same distance categories.
Xenopus tropicalis ortholog identiﬁcation and in situ hybridization
X. tropicalis orthologs of candidate human Nodal signaling target
genes were identiﬁed by overall sequence homology validated by
synteny between the human and X. tropicalis sequences (identiﬁed
using Metazome). ESTs for the corresponding X. tropicalis gene were
identiﬁed using the JGI genome browser, and IMAGE clones
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hybridization. Linearized plasmid was reverse-transcribed and la-
beled with DIG-UTP according to standard methods, and in situ
hybridization using a multibasket technique was carried out as
described in Khokha et al. (2002).
Histone peak clustering
We used K-means clustering (http://bonsai.ims.u-tokyo.ac.jp/
~mdehoon/software/cluster/software.htm) to visualize the H3K4me3
andH3K27me3 surrounding TSS in the genome. Thewiggle/enrichment
plots represent normalized enrichment over the background. The data
points were the normalized enrichment values that are calculated by
QuEST. The log2(enrichment) values were used for clustering and
plotting. H3K4me3 and H3K27me3marks were analyzed depending on
their patterns within ±5 kb of the TSS from UCSC Known Genes. For
gene loci with isoforms with alternate TSS's, we chose the TSS with the
largest H3K4me3 peak. Genes with a TSS within 10 kb of another gene
TSS were discarded for clustering analysis.
To functionally deﬁne these clusters, GO analysis was performed
using PANTHER (Protein Analysis through Evolutionary Relation-
ships) (www.pantherdb.org). In addition, we examined how Groups
1–9 are correlated with transcriptional activation in the context of
endoderm. To this end we used microarray timecourse of hESC
differentiation into endoderm to associate the behavior of transcripts,
whether induced, constitutive, inactive or repressed with a speciﬁc
histone grouping (1–9). We compared the transcriptional levels of
day 5 derived endoderm (d5) with hESCs (d0). For each gene, we
calculated the fold change (R), difference (D) between the means of
the two groups, and the Welch's t-test p-value using dChip (Li and
Wong, 2001). Induced genes were deﬁned by RN2 and DN100 of d5
over d0, and P≤0.05. Repressed genes were deﬁned by RN2 and
DN100 of d0 over d5, and P value≤0.05. We also calculated the
logarithm-transformed average (A) and difference (M) of the means
of d0 and d5 for each gene. We calculated the z-scores of A (ZA) and
the z-scores of M (ZM) for all genes. Constitutive genes were deﬁned
by ZAN1 and ZMb1. Inactive genes were deﬁned by ZAb−1 and ZMb1.
Results
Timecourse microarrays and extensive protein validation support
endoderm formation from hESCs
To characterize the downstream Nodal targets during the differen-
tiation of hESCs into the endodermal lineage and to determine how this
important signaling pathway interacts with chromatin, we ﬁrst
extensively validated our derivation of endodermal cells from hESCs.
To this end, endodermal cells were derived from hESCs after a 5-day
treatment with Activin (Fig. 1A), which acts as a Nodal analog (McLean
et al., 2007; Schier, 2003; Shen, 2007). The efﬁciency of endoderm
differentiation was rigorously examined usingmultiple methodologies,
including determining the transcriptome of cells through time,
analyzing the expression of endoderm speciﬁc proteins – with and
without Nodal chemical inhibitors – and validating each timecourse
using qPCR. To this end, we performed an extensive microarray
timecourse during hESC differentiation into endoderm post Activin
treatment, examining at days 0, 1, 3 and 5. The timecourse microarray
data were deposited to the publicly available repository of GEO
(accession number GSE29421). Several critical lineage speciﬁcation
genes including GSC,MIXL1 and EOMES are highly enriched (more than
40 fold) after the ﬁrst 24 h of differentiation (Fig. 1B). Mesodermal
markers are also expressed after 24 h of differentiation, including BRA
and FGF4 suggesting the presence of a mesendodermal intermediate
(Fig. 1B) (D'Amour et al., 2005; Liu et al., 2007). The transcripts of
endoderm markers SOX17, FOXA2 and CXCR4 are upregulated (6–22
fold) as early as day 3 of differentiation while markers for other germlayers, including mesoderm, are no longer expressed. Also, starting at
day 3 of differentiation the protein levels of endodermmarkers GATA4,
GATA6, SOX17 and FOXA2 are induced (Fig. 1C).
While extensive transcript proﬁles have been examined during
endoderm commitment after exposure of hESCs to Activin, the
dynamics of protein expression and sensitivity to Activin signals
have not been demonstrated (D'Amour et al., 2005; Liu et al., 2007).
Using western analysis to examine protein expression and its
dependency on Nodal signaling, we examined multiple endodermal
markers as well as the SMAD2/3 and FOXH1 proteins themselves
throughout the course of endoderm differentiation at days 0, 1, 3, 4
and 5 post Activin treatment in the presence or absence of the Nodal
chemical inhibitor, SB431542. This SB431542 inhibitor is known to
be speciﬁc for SMAD2/3 signaling by inhibiting type I TGF-β
receptors and has been studied in hESCs (Vallier et al., 2009; Xu et
al., 2008). Here we show that the expression of phosphorylated
SMAD2 (pSMAD2) and FOXH1 is upregulated in the nucleus as early
as day 1 of differentiation after exposure to Activin. These proteins
are clearly co-localized within the nucleus of the derived endodermal
cells (Fig. 1D, E and F). Furthermore, pSMAD2 and FOXH1 expression
is highly dependent on Nodal signaling as both proteins diminish
following SB431542 treatment (Fig. 1E). Additionally, the endoderm
markers LEFTY, GATA4, GATA6 and SOX17 were highly induced
during differentiation as early as day 3 and maintained high level of
expression throughout the rest of the timecourse (Fig. 1G). OCT4, a
pluripotency marker, was strongly expressed in the nucleus of hESCs
but decreased sharply during endoderm differentiation (Fig. 1C and
E). This pattern is not the same for the OCT4 transcript, which remains
abundant during the ﬁrst few weeks of hESC differentiation in our
timecourse microarray data, suggesting that the expression of OCT4 is
more tightly controlled posttranscriptionally. When SB431542 was
added during the third day of differentiation in Activin, LEFTY and
GATA6 expression rapidly decreased within 24 h. Conversely, GATA4
and SOX17 showed weak or little reduction in protein in response to
Nodal signaling inhibitionwhen occurring on the third day of endoderm
differentiation suggesting they are less dependent uponNodal signaling
or that theseproteins aremore stable. Interestingly,wehave also shown
that protein expressions of LEFTY, GATA4, GATA6 and SOX17 were
completely inhibited if we treated cells with SB431542 at the beginning
of differentiation of hESCs rather than day 3 differentiated cells,
conﬁrming that the initial expression of GATA4, GATA6, SOX17 and
LEFTY are all dependent on Activin treatment (Yoon et al., unpublished
results). Taken together, these results validate that, as in earlier studies,
Activin/Nodal signaling drives deﬁnitive endoderm formation in hESCs
and demonstrate fundamental expression differences in response to
Nodal signaling.
Genome-wide target analysis of SMAD2/3/4, FOXH1, H3K4me3 and
H3K27me3 in hESCs and derived endoderm
To examine the dynamics of the Nodal signaling pathway and
associated chromatin marks during differentiation of hESCs into
endoderm, we performed genome-wide location analysis using ChIP-
seq for SMAD2/3, SMAD3, SMAD4, FOXH1,H3K4me3 andH3K27me3. To
this end, we examined multiple antibodies against SMAD2/3, SMAD3,
SMAD4andFOXH1 for their ability topull downchromatin inbothhESCs
and derived-endoderm and found several, including two SMAD2/3
antibodies (anti-rabbit; SMAD2/3_Aand anti-goat; SMAD2/3_B, Table 1)
neither ofwhichwere phospho-speciﬁc, butwhichwere highly effective
for ChIPbased upon extensive validation shown in Fig. S1. By usingChIP-
qPCR, we analyzed the enrichment of several known SMAD targets,
including LEFTY1 and LEFTY2 (Fig. S1A) in all SMAD2/3, SMAD3, SMAD4
and FOXH1 ChIP samples. GAPDH intronic sequences were used as
negative control. After validation, three biological replicate ChIPs were
pooled from each antibody, as well as input controls, for both hESCs and
derived endoderm. Libraries were then generated and sequenced with
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Fig. 1. Endoderm differentiation and validation. (A) Diagram for endoderm differentiation from hESCs. (B) Microarray expression data for lineage markers. Average expression was
presented from array datasets of individual biological replicates for each gene over the timecourse. (C) Western blots for known endoderm regulators GATA4, GATA6, SOX17 and
FOXA2. OCT4 is a marker for hESCs. Hep; HepG2 cell lysate as a positive control for FOXA2. (D)Western blots for phosphorylated SMAD2 and SMAD3 (pSMAD2 and pSMAD3). K562;
positive control cell lysate for total SMADs but negative for pSMADs. (E) Western blots for samples after cellular fractionation or in the presence of SB431542. Nuc; nuclear lysate,
Cyto; cytosolic lysate, Act; Activin treated, SB; SB431542 treated. (F) SMAD2/3 and FOXH1 immunohistochemistry on derived endoderm. (G) Western blots for known endoderm
regulators and Nodal targets in the presence of SB431542 for speciﬁed duration. Act; Activin treated, V; the vehicle (ethanol) only, SB; SB431542 treated.
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mapped to the human genome (hg18) using Eland and binding sites
were identiﬁed using CisGenome (Ji et al., 2008). The ChIP-seq data are
available in GEO (accession number GSE29422). For SMAD2/3_A,
SMAD2/3_B, SMAD3, SMAD4 and FOXH1, we generated 10.2, 8.7, 6.9, 9
and 10.4 million mapped reads in hESCs and 9.6, 5.9, 6.1, 6.1 and
10.8 million mapped reads in derived endoderm, respectively (Table 1).
Since there were thousands of SMAD bound regions in both hESCs and
endoderm, we validated these datasets using two methods. First, we
compared bound regions elucidated from the two SMAD2/3 antibodies
(A and B) and found a high degree of overlap in both hESCs and derivedendoderm (93% and 78%, respectively), showing that two independent
antibodies pulled down highly overlapping regions. As the overlap was
extensive, and the Bdatasetwas farmore comprehensive, all subsequent
analysis was performed using the B dataset. The degree of overlap
generated from two independent antibodies highly validates thedataset.
Examples of bound regions are illustrated in Fig. 2. For further validation,
we performed ChIP-qPCR at predicted loci with or without SMAD
signaling present. To this end, we treated hESCs with SB431542 during
the ﬁrst 24 h of differentiation. We then examined by ChIP-qPCR
whether SMAD2/3 and FOXH1 were still associated with the predicted
binding regions in the absence of Nodal signaling. We found that every
Table 1
ChIP-seq analysis summary. The numbers of reads, peaks and associated genes of all transcription factors and histone marks studied in hESCs (hESC) and derived endoderm (Endo).
ChIP Cell Reads Peaks
Associated genes (kb)
1000 100 10 1
SMAD2/3_A hESC 10,200,000 4,032 3,588 3,077 1,916 1,249
Endo 9,605,287 1,037 1,117 827 272 72
SMAD2/3_B hESC 8,708,351 14,833 9,777 9,052 7,057 5,715
Endo 5,910,789 2,915 2,604 1,905 567 106
SMAD3 hESC 6,928,056 2,688 2,511 2,062 1,197 745
Endo 6,055,629 2,296 2,107 1,466 400 67
SMAD4 hESC 8,959,821 3,936 3,533 3,223 2,293 1,702
Endo 6,066,743 4,531 2,768 2,753 906 207
FOXH1 hESC 10,400,000 9,702 6,897 5,797 2,646 1,123
Endo 10,800,000 29,292 11,631 10,385 4,734 1,324
Input hESC 9,465,441 – – – –
Endo 9,716,862 – – – –
H3K4me3 hESC 7,338,695 24,030
Endo 10,326,110 29,688
H3K27me3 hESC 17,893,702 13,936
Endo 19,595,165 26,293
Input hESC 8,824,050 –
Endo 10,876,757 –
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Fig. 2. SMAD2/3/4 binding, H3K4me3 and H3K27me3 at EOMES and GSC loci in hESCs and derived endoderm. UCSC genome browser screen shots of EOMES and GSC in hESCs (hESC,
blue) and derived endoderm (Endoderm, red). Binding regions of SMAD2/3_A and SMAD3 ChIP-seq dataset are shown as bars and others are shown as peaks. Dotted boxes indicate
unique regions of SMAD2/3 and SMAD4 binding in derived endoderm, and asterisk indicates the known Activin response element in the GSC promoter region (Danilov et al., 1998).
K4me3 and K27me3 stand for H3K4me3 and H3K27me3, respectively.
496 S.W. Kim et al. / Developmental Biology 357 (2011) 492–504
010
20
30
40
50
0
10
20
30
40
50
Exon
Intron
Promoter
Intergenic
hESC Endoderm
SMAD2/3 SMAD3 SMAD4 FOXH1 SMAD2/3 SMAD3 SMAD4 FOXH1
A
B
D
C
GADD45A
A
V
FZD8
A
V
LHX1
A
V
CYP26A1
A
V
GSC (+control)
A
V
Peaks
CSEhCSEh Endo Endo
Genes
629
914
211
1,004
SMAD2/3
SMAD3
1,87926 8,506
FOXH1 SMAD4
45914,374 1,1347,918 7712,456
SMAD2/3
2,69459 7,691
FOXH1
227
45
206
SMAD4
%
/T
o
ta
l P
e
a
k 
R
eg
io
ns
Fig. 3. SMAD proteins exhibit dynamic binding during endoderm differentiation. (A) Genomic distribution of transcription factor binding sites. SMAD2/3, SMAD4 and FOXH1 peaks
were classiﬁed into annotated genomic regions — exon, intron, promoter or intergenic region using UCSC Known Genes (Human browser hg18). Promoter regions are deﬁned as
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100 kb from TSS. Left diagrams are comparison of SMAD2/3 and FOXH1(chi-square Pb1.0E–228). Center diagrams are comparison of SMAD4 and FOXH1 targets (chi-square Pb1.0E–
228). Right diagrams are comparison of all SMAD targets (all chi-square P of each overlap between two SMADs were b1.0E–228). (D) Wholemount in situ hybridization analysis of
SMAD2/3 target genes in X. tropicalis embryos (gastrula, stage 11). Embryos are shown in dorsal views with animal (A) to the top and vegetal (V) to the bottom. A known Nodal
signaling target expressed in the dorsal mesoderm, GSC, is shown as a positive control. Examples are shown for SMAD2/3 targets expressed in the dorsal mesoderm (GADD45A,
LHX1), dorsal endoderm (FZD8), and throughout the mesoderm (CYP26A1) regions of the embryo that are highly responsive to Nodal signaling.
497S.W. Kim et al. / Developmental Biology 357 (2011) 492–504examined region was affected by SB431542 treatment, strongly
indicating that they are regions bound directly by SMAD2/3 and
FOXH1andaredownstreamtargets ofNodal/Activin signaling (Fig. S1B).
For H3K4me3 and H3K27me3, we generated 7.3 and 17.9 million
mapped reads in hESCs and 10.3 and 19.6 million mapped reads in
derived endoderm, respectively (Table 1). Since H3K4me3 and
H3K27me3 marks have far wider distribution than the binding of
transcription factors, we sought to address whether our depth of
sequencing reached saturation. To this end,we called peaks frompooled
reads (two biological replicates for H3K4me3 and three for H3K27me3)
and checked the levels of saturation of unique peaks called. H3K4me3
reads reached saturation, but not H3K27me3 even after additional
sequencing (Fig. S2). These data suggest that either more extensive
sequence depth might be necessary or that H3K27me3marks are more
variable than H3K4me3marks, consistent with initial data generated inhESCs andanalysis performedby Sharov andKo(2007) (Panet al., 2007;
Zhao et al., 2007; available in GEO: GSE29422).
SMAD2/3/4 associatewith different regions in hESCs and derived endoderm
To determine how dynamic SMAD and FOXH1 binding is between
hESCs and derived endoderm, we examined the genomic distribution
of identiﬁed Nodal signaling peaks. We ﬁrst designed a Python script
to search through UCSC Known Genes (Human browser hg18) to
locate the peaks into annotated exon, intron, promoter or intergenic
regions (Fig. 3A).We found that in hESCs, SMAD2, SMAD3 and SMAD4
are bound at similar frequencies to each of these genomic regions
with 50–60 % of binding occurring in exons and promoters. In
contrast, in derived endoderm, only 10–15 % of SMAD binding occurs
in exons and promoters. Surprisingly, the genomic distribution of
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Fig. 4. Expression correlation of transcription factor binding at distances from TSS and correlation with multiple binding events. Expression levels of genes neighboring transcription
factor binding sites at different distances (b1 kb, 1 kbb10 kb, and 10 kbb1 Mb) in hESCs (A) and endoderm (B). “None” (in A and B) indicates genes that do not have surrounding
sites for SMAD2/3, SMAD3, SMAD4 and FOXH1 within given distance. Expression levels of genes with multiple transcription factor binding sites in hESCs (C) and endoderm
(D). Genes bound by transcription factors within 10 kbwere analyzed. “None” (in C and D) are genes that do not have any binding regions of SMAD2/3, SMAD3, SMAD4 and FOXH1 at
the given distance. Box plots show 25th, 50th, and 75th percentiles of log2 expression levels for genes in each group. Whiskers represent 5 and 95 percentile of genes in each group.
Student t-tests were performed on each group comparingwith appropriate ‘None’ group. One asterisk denotes Pb0.05 and two asterisks Pb0.01. The presence of a SMAD2/3, SMAD3,
SMAD4 or FOXH1 binding event within 1 kb from TSS is signiﬁcantly correlated with an increase in transcriptional levels, above background levels (In hESCs, P=1.5E–50, 5.6E–38,
2.5E–15 and 5.6E–16, respectively; In endoderm, P=3.5E–12, 8.7E–12, 1.7E–05 and 4.3E–12, respectively). Further, the presence of three or more binding regions of SMAD2/3,
SMAD3, SMAD4 or FOXH1 is highly correlated with increased transcription levels in endoderm, above background levels (In hESCs, P=2E–10, 9.2E–08, 6E–05 and 7.8E–04,
respectively; In endoderm, P=1.5E–22, 9.5E–16, 1.7E–09 and 7.9E–07, respectively).
498 S.W. Kim et al. / Developmental Biology 357 (2011) 492–504FOXH1 peaks remains more constant between these two cell types,
exhibiting a high degree of binding (80–85%) outside exons and
promoters. This mimics the distribution of SMADs within derived
endoderm, but not in hESCs. These observations suggest that SMAD
transcription factors are highly dynamic in regard to their genomic
distribution evenwithin the5 days that separate hESCs fromendoderm.
As SMAD binding is dynamic between hESCs and derived
endoderm, we sought to deﬁne how these peaks are utilized in the
different cells. By analyzing the common sites for each transcription
factor in both hESCs and derived endoderm, we found that most of the
SMAD peaks change upon differentiation. Only 3% (459/14,833) of
SMAD2/3 peaks in hESCs are retained in the derived endodermal cells
(Fig. 3B). A similar pattern is observed for SMAD3 (6.7%; 180/2688)
and SMAD4 (8.8%; 345/3936). On the other hand, FOXH1 retains
almost 50% (4346/9702) of its hESCs peaks upon differentiation
toward endoderm, while the large number of additional sites is
observed in derived endoderm. Together, this suggests that a vast
change in transcription factor occupancy is triggered upon differen-
tiation toward endoderm.
SMAD2/3/4 associate with similar genes in hESCs and derived endoderm
Although SMAD2/3 binding is highly dynamic at bound regions
during differentiation into endoderm, we asked whether theseregions are associated with similar genes. To this end, we associated
bound regions for all transcription factors with the nearest gene TSS
(UCSC Known Gene) within 1000 kb (1 Mb), 100 kb, 10 kb and 1 kb
(Table 1). To validate whether these genesmight be involved in SMAD
signaling, we stringently selected a high value group of 322 target
genes by examining regions bound by all SMAD2/3, SMAD3 and
SMAD4 in both of hESCs and endoderm (see Supplemental excel ﬁle).
To obtain spatial information in the embryo, we then cloned the
X. tropicalis orthologs of 42 of these target genes and performed in situ
hybridization during gastrulation stages. We found that 45% (19/42)
of these had speciﬁc endoderm or mesoderm expression patterns
during gastrulation. This is an extremely high hit rate, especially
considering that 29% (12/42) of the probes did not provide a signal,
which could simply be due to probe design. Some of these expression
patterns are represented in Fig. 3D, while the rest are in Supplemental
Figure S3. Overall this suggests that the SMAD target datasets do
indeed identify neighboring genes that are expressed embryonically
at the temporal and spatially appropriate times for being involved in
Nodal signaling.
To determine the overlap between genes neighboring SMAD bound
regions, we compared target genes between hESCs and derived
endoderm. We found that the genes associated near SMAD bound
regions remained more consistent between hESCs and derived endo-
derm compared to the regions themselves. For example, 60%
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Fig. 5. H3K4me3 and H3K27me3 clusters demonstrate new bivalent groups. (A) K-means clustering was performed to visualize H3K4me3 (K4) and H3K27me3 (K27) marks
surrounding 16,621 TSSs. Promoter regions covered were±5 kb from TSS. Yellow areas are the regions of the log2 peak intensity higher than zero; black areas close to zero; and blue
areas lower than zero. TSS indicated by blue arrow (bottom). (B) Sequential ChIP for H3K4me3 (K4) and H3K27me3 (K27) to validate bivalent domains in Group 1, Group 5 and
Group 6. Sequential ChIPs were performed with anti H3K27me3 and H3K4me3 antibodies in hESCs and CXCR4 positive endodermal cells. Fold enrichment for each ChIP was
calculated compared to the value of SERPINA1, a negative control for H3K4me3 and H3K27me3.MYOD and ASCL1 belong to Group 1, KCND2 to Group 5, LECT1 and CLDN10 to Group 6,
and GAPDH to Group 3. K27_K4; 1st ChIP with K27 and 2nd ChIP with K4, K27_K27; both 1st and 2nd ChIP with K27, K27_IgG; 1st ChIP with K27 and 2nd ChIP with rabbit total IgGs,
K27(10%); 10% of 1st K27 ChIP.
499S.W. Kim et al. / Developmental Biology 357 (2011) 492–504(1134/1905) of the genes neighboring SMAD2/3 sites in derived
endoderm were also associated in hESCs, compared to 16% (459/2915)
when comparing genomic binding sites alone (Fig. 3B and Supplemental
ﬁle). Thus while individual SMAD proteins associate with DNA in a
dynamic fashion during differentiation, they tend to occupy regions
surrounding similar genes, suggesting that different loci within gene
regulatory domains are used to mediate distinct cellular transcriptional
responses.
SMAD2, SMAD3, SMAD4 and FOXH1 are known to regulate similar
downstream targets in a variety of cellular contexts and are known to
formcomplexes at these sites (Attisanoet al., 2001; Silvestri et al., 2008).
Therefore, we examined the overlapping targets between these
transcription factors. We found that, in both hESCs and derived
endoderm, all SMAD transcription factors are bound near a highlyoverlapping set of genes, regardless of the distance examined from TSS
(Fig. 3C, S4 andSupplementalﬁle)withmost boundbyall threeproteins
(1004 within 100 kb). Comparison between the putative target genes
for the SMAD2, SMAD3 and SMAD4 with those of FOXH1 shows that
while some overlap exists in hESCs (Fig. S5), due to the overwhelming
genome-wide occupancy of FOXH1, it is extensive in derived endoderm,
encompassing almost all (99%; 1879/1905) of SMAD2/3 and (98%;
2694/2753) of SMAD4 target genes within 100 kb (Fig. 3C).
Proximal SMAD2/3/4 and FOXH1 complexes are predictive of
gene transcription
SMAD2, SMAD3, SMAD4 and FOXH1 bind thousands of regions
genome wide, but since transcription factor binding does not
500 S.W. Kim et al. / Developmental Biology 357 (2011) 492–504necessarily affect transcriptional activity, we sought to understand
how these binding signatures correlate with gene expression output.
Byusing the timecoursemicroarray (days 0, 1, 3 and 5) and the ChIP-seq
target datasets, we can identify the bound sites correlated with
increased transcription. Several critical lineage speciﬁcation genes
including GSC, MIXL1 and EOMES are highly enriched (more than 40
fold) after the ﬁrst 24 h of differentiation (Fig. 1B). SMAD proteins are
bound to regions surrounding each of these developmentally important
genes in both hESCs and derived endoderm. In each cellular context the
nature of SMAD2/3/4 binding changes (Fig. 2). For example, upon
differentiation to endoderm, EOMES and GSC are bound by SMAD2/3/4
in regions not bound in hESCs (Fig. 2 dotted black boxes). Conversely,
several regions bound in hESCs are lost in endoderm.
To elucidate the most predictive signature of SMAD2/3/4 or FOXH1
binding that can be correlated with transcriptional activation, weA
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Fig. 7. SMAD2/3 binding and H3K27me3 depletion occur simultaneously. (A) H3K4me3 (K4) and H3K27me3 (K27) binding dynamics in promoter regions of GSC and EOMES. ChIP-
qPCR was performed in hESCs (left) and endoderm (right). 5′; loci further upstream 5 kb from TSS, TSS; loci within 5 kb from TSS, 3′; loci downstream of transcription termination
site. GAPDH is a positive control for H3K4me3 and a negative control for H3K27me3. (B) H3K27me3 depletion in EOMES promoter occurs within the same nucleosome. Sequential
ChIP was performed with anti H3K27me3 (K27) and H3K4me3 (K4) antibodies in hESCs and CXCR4 positive endodermal cells. Fold enrichment for each ChIP was calculated
compared to the value of SERPINA1, a negative control for H3K4me3 and H3K27me3. The EOMES_TSS primer set was used for qPCR. K27_K4; 1st ChIP with K27 and 2nd ChIP with K4,
K27_K27; both 1st and 2nd ChIP with K27, K27_IgG; 1st ChIP with K27 and 2nd ChIP with rabbit total IgGs, K27(10%); 10% of 1st K27 ChIP. (C) ChIP-qPCR for SMAD2/3, FOXH1 and
H3K27me3 (K27) in the promoter regions of GSC and EOMES during hESC differentiation at 6, 12 and 24 h after Activin treatment. GAPDH is a negative control for SMAD2/3 and
FOXH1 binding. (D) ChIP-qPCR for JMJD3 in the promoter regions of GSC and EOMES during hESC differentiation at 6, 12 and 24 h after Activin treatment. GAPDH is a negative control
for JMJD3 binding.
501S.W. Kim et al. / Developmental Biology 357 (2011) 492–504events were more predictive of transcriptional activity than isolated
binding events. In derived endoderm, we ﬁnd that multiple binding
events within the extended promoter region are highly correlated with
increased transcription levels. Further, the more bound regions within
this interval, the more signiﬁcant the correlation. This correlation is
particularly strong for regions containing three or more SMAD2/3 or
SMAD3 bound sites in derived endoderm (Student's t-test; P=1.5E–22
and 9.5E–16, respectively; Fig. 4C andD). In hESCs, all SMAD association
within 10 kb is highly predictive of transcriptional increase. Overall, this
data strongly suggests that in endodermal cells, Nodal signaling targetsare more likely to be transcriptionally activated if surrounded by
concentrated regions of binding within 10 kb of the TSS.
Endoderm differentiation involves establishment of new bivalent
domains
As it is known that occupancy of H3K4me3 and H3K27me3
changes during differentiation, particularly at bivalent regions, we
sought to examine how these marks change during endoderm
commitment. To this end, we used K-means clustering to visualize
502 S.W. Kim et al. / Developmental Biology 357 (2011) 492–504H3K4me3 and H3K27me3 enrichment in a 10 kb centered window
around 16,621 TSSs in both hESCs and derived endoderm (Heintzman
et al., 2007; Hon et al., 2008). This analysis led to a clear demarcation
of nine different groups (1–9) containing unique signatures that exist
in both cell types (Fig. 5A and Supplemental ﬁle). Gene ontology (GO)
analysis revealed highly signiﬁcant and unique biological functions for
different groups (Table S1 and Supplemental ﬁle), particularly the
bivalent group with the strongest and widest H3K27me3 marks,
which is highly signiﬁcant for genes with roles in developmental
processes (Group 1; Developmental group; P=1.1E–88) (Bernstein et
al., 2006; Ku et al., 2008). Indeed Group 1 contains the key regulators
of endoderm formation, including EOMES, GSC, PITX2, SOX17, GATA4
and GATA6.
While it is known that the bivalent motif exists in various forms
(Cui et al., 2009; Ku et al., 2008; Mikkelsen et al., 2007; Pan et al.,
2007), we were surprised to see how many different patterns
emerged upon clustering. Interestingly, differentiation into endoderm
appears to not only maintain many bivalent domains from hESCs, but
also establishes new bivalent domains as well. To test whether these
groups reﬂected true bivalent domains where both marks were
present on the same nucleosome and not the result of heterogenous
endoderm populations, we performed sequential ChIP-qPCR for
H3K4me3 and H3K27me3 at speciﬁc promoters in both hESCs and
derived endoderm. We examined the promoters of MYOD and ASCL1
(which belong to Group 1), KCND2 (Group 5), LECT1 and CLDN10
(Group 6), and GAPDH (Group 3). These promoters were selected
from each group to represent the different bivalent domains depicted
in Fig. 5A. In both hESCs and derived endoderm, we performed ChIP
ﬁrst with anti-H3K27me3 and then reprecipitated with anti-
H3K4me3. Total rabbit IgGs were a negative control for the second
pulldown. We ﬁnd that in each case the sequential ChIP results support
theﬁnding thatbothmarksare presentwithin a singlenucleosomeor, at
least, the histone marks are on adjacent nucleosomes (as we sonicated
DNA to generate 200- to 600-bp fragments). For example, the clustering
of Group 1 promoters demonstrates broadH3K4me3 and H3K27me3 in
bothhESCs andderivedendoderm(Fig. 5A). Sequential ChIP shows that,
at the Group 1 genes,MYOD and ASCL1, the bivalent mark is present in
the same or neighboring nucleosomes in both cell types (Fig. 5B).
Whereas in Groups 5 and 6 promoters, which become bivalent only in
derived endoderm, sequential ChIP at KCND2 (Group 5), LECT1 (Group
6) and CLDN10 (Group 6) promoters show bothmarks present together
only in derived endoderm (Fig. 5B). Overall, sequential ChIP supports
the hypothesis that bivalent domains are both maintained and
enhanced in derived endoderm.
Endoderm-speciﬁc transcription in Group 1 is associated with
H3K27me3 depletion and SMAD2/3 accumulation
While bivalent regions are prevalent in endoderm, we asked
whether these domains were altered at actively transcribed genes. To
this end, we correlated each promoter group (1–9) with induction of
transcription during differentiation into endoderm. Histogram plots
of the amount of H3K4me3 and H3K27me3 at each induced region for
each group are shown in Fig. 6A. While the bivalent conformation is
still observed, H3K27me3 levels are depleted and H3K4me3 increased
only at promoters in Group 1 and in Group 4 in this endodermally
expressed subset (Groups 1 and 4; all P for H3K4me3 and H3K27me3
were b1.0E–06, see Material and methods for statistical analysis).
Overall this suggests that the promoters of Group 1 genes that are
associatedwith transcriptional activation, exhibit relative depletion of
H3K27me3 and accumulation of H3K4me3.
We next determined whether SMAD2/3 binding could be
associated with the chromatin changes observed at these few loci in
the Group 1 bivalent domains. To this end, we examined whether
SMAD2/3 binding within 100 kb of the TSS could be associated with
the H3K27me3 depleted regions. Of the 32 Group 1 promoter regionsassociated with endodermal transcriptional activation, 21 genes were
bound within 100 kb by SMAD2/3. All 21 of these regions displayed
almost complete depletion of H3K27me3 in endoderm compared to
the other bivalent genes in Group 1 (Figs. 2 and 6B) (both P for
H3K4me3 and H3K27me3 were b1.0E–06). Interestingly, the 21
bound regions included EOMES, GSC, SOX17, GATA4, GATA6 and FOXA2,
all known to play important roles in endoderm commitment (Fig. 2
and Table S2). The remaining 11 regions of Group 1, which are
associated with transcriptional activation and chromatin alterations,
are not bound by SMAD2/3 within 100 kb. However, they are bound
by SMAD4 or by SMAD2/3 using other criteria: this includes four
genes, NOG, HNF1B, AHNAK and MSX2, which are bound by SMAD4
within 100 kb, and four genes,NOG, PCDH7, CYP26A1 andMSX2, which
are bound by SMAD2/3 within 1 Mb. We further validated this result
by examining biochemically H3K4me3 and H3K27me3 marks in
hESCs and derived endoderm at two of the 21 ‘resolving promoters’
(Fig. 7A).WeperformedChIP-qPCRusing primers that tiled theGSCand
EOMESpromoters forH3K4me3 andH3K27me3 (Fig. 2). Importantly, in
agreement with our ﬁndings from genomic analysis, H3K27me3 is
depleted or signiﬁcantly reduced across the promoters only after
endoderm differentiation. In addition, we examined whether the
H3K27me3 depletion occurs in the same nucleosome during differen-
tiation. To this end, we performed sequential ChIP-qPCR for H3K4me3
and H3K27me3 in hESCs and endoderm at the EOMES promoter. Both
marks are precipitated together in the hESC nucleosomes of the EOMES
promoter, but not in derived endoderm, further indicating that at these
loci and within the same nucleosome the bivalent domain has been
resolved (Fig. 7B). Taken together, this suggests that SMAD2/3 or a
family member plays an important role in bivalent resolution within
these regions which are critical for endodermal speciﬁcation and
provides a system in which to study how these key ‘poised’ regions
become activated.
SMAD2/3, FOXH1, JMJD3 and H3K27me3 association dynamics during
the ﬁrst 24 h of differentiation
AsH3K27me3 depletion occurs at active Group 1 bivalent promoters
associated with SMAD2/3, we next investigated the kinetics of this
depletion over the course of 24 h. Since it was shown recently that
SMAD2/3 can recruit the histone demethylase, JMJD3, to the NODAL
promoter where it actively demethylates H3K27me3 (Dahle et al.,
2010), we further propose that this might be a common mechanism
occurring within the 32 Group 1 resolving promoters. Therefore, we
performed timecourse ChIP-qPCR using SMAD2/3, FOXH1, H3K27me3
and JMJD3 during hESC differentiation into endoderm at 6, 12, and 24 h
at two sites near GSC and EOMES. Surprisingly, we ﬁnd that most of the
SMAD2/3, FOXH1 and JMJD3 accumulation and H3K27me3 depletion
occur simultaneously, evenasearly as 6 hpostActivin treatment (Fig. 7C
and D). Interestingly, while SMAD2/3 and FOXH1 binding at these
regions continues to increase throughout the 24 h window, JMJD3
appears to peak at 6 h, diminishing by 24 h. This is consistent with
JMJD3 role as a demethylase as by 24 h there is far less association of
H3K27me3 to these regions, suggesting that the methylation is lost
rapidly within the ﬁrst day of differentiation and that JMJD3 plays a key
role, not only at the NODAL locus, but also at many others as well. These
protein dynamics are highly consistent with the transcriptional
activation of GSC and EOMES, which are rapidly transcribed in the ﬁrst
24 h after Activin treatment, at levels 40–50 fold higher than found in
hESCs.
Discussion
A single broad class of bivalent domains known to be highly
enriched at promoters for important developmental factors has been
proposed to be ‘poised’ for rapid differentiation. Here we provide
genomic and biochemical evidence that substantiate this observation,
503S.W. Kim et al. / Developmental Biology 357 (2011) 492–504at least during endoderm commitment from hESCs. We ﬁnd that
within the developmental class of bivalent promoters (Group1),
SMAD2/3, FOXH1 and JMJD3 accumulate simultaneously with the
depletion of H3K27me3 within the ﬁrst 24 h of differentiation. This
occurs at critical promoters for endoderm commitment, including GSC
and EOMES, correlating with their transcriptional activation within the
24 h of Activin treatment. Furthermore, this implies that resolution of
bivalent domains upon differentiation at critical promoters involves
interplay between transcription factors and associated chromatin
marks. In the case of endoderm, this association appears to be occurring
at very few regions. This study presents thousands of regions bound by
the SMAD complex and then narrows these regions down to a critical 32
that appear to be central to endoderm commitment. In the future it will
be very interesting to understandmechanistically how these 32 regions
are singled out for JMJD3 association and subsequent bivalent
resolution.
Intriguingly, we observed an increase in bivalent domains as hESCs
differentiate into endoderm. This maintenance and expansion of
bivalent promoters is distinct from many other cell types. While
bivalent domains are prevalent in hESCs, encompassing more than
2000 promoters in the genome, most of these bivalent domains
becomemonovalent in more differentiated cell types (Bernstein et al.,
2006; Cui et al., 2009; Mikkelsen et al., 2007; Pan et al., 2007; Zhao et
al., 2007). While a small fraction (less than 20%) of monovalent genes
have been shown to become bivalent in more differentiated cell types
including MEFs and NPCs (Mikkelsen et al., 2007; Zhao et al., 2007),
we showed that most of the monovalent genes marked by H3K4me3
appear to become bivalent during endoderm formation (as observed
in Groups 3, 5, 6 and 7). We suggest that this increase in bivalent
promoters in endodermal cells is due to the fact that endoderm is one
of the ﬁrst cell types that arise in the embryo and therefore must
maintain a degree of plasticity. It may therefore be expected that
multipotent cell types in general retain a bivalent conformation at
many promoters and may even utilize new subtleties in this
conformation to activate gene transcription.
As cells differentiate into endoderm, SMADtranscription factors bind
to discrete target sequences. Some of these binding events lead to gene
transcription, while others remain ‘inert’. Though the mechanics that
govern the selection between these activities is unknown, it is becoming
clear that chromatin plays a key role. Recently, a number of studies have
shown that the levels of histone methylation and the recruitment of
histonemethyltransferasewith transcription factors are critical for their
transcriptional activity (Cheng et al., 2009; Demers et al., 2007;
McKinnell et al., 2008; Miller et al., 2008). In agreement with this
view, we have deﬁned subtle classes of bivalent domains, each with
distinct annotations, transcriptional responses, and binding variability
within the endoderm. Group 1 represents the bivalent domain whose
function is to regulate ‘Developmental Genes’ which recapitulates
previous ﬁndings (Bernstein et al., 2006). In addition, we showed
another subclass bivalent group,Group4,which is strongly annotated to
neuronal activities (122/414 genes (29.5%), Bonferroni P=1.08E–20)
and cell communication (167/849 genes (19.7%), Bonferroni P=3.27E–
1). Group 4 is likely to represent the bivalent domainswhose function is
to fulﬁll cell signaling as previously discussed (Ku et al., 2008). Since
these various bivalent groups revealed in derived endoderm are
associated with distinct annotations and display unique histone
marks, they can be further classiﬁed into the types associated with
Polycomb repressive complexes (PRC) (Ku et al., 2008). Groups 1 and 4
are likely to be PRC1-positive because they exhibit large H3K27me3
regions and maintain the bivalent conformation during differentia-
tion as well as are strongly annotated to development and cell
signaling. Interestingly, Groups 5, 6 and 7 are likely to contain PRC1-
negative bivalent domains which emerge during endoderm forma-
tion as they display narrow H3K27me3 regions and are associated
with non-developmental functions such as protein and DNA
metabolism.While many inroads have been made in understanding endoderm
formation in vertebrates, the next paradigm shifts in embryology will
be advanced by the application of new technologies. As ChIP-seq
becomes more utilized in the scientiﬁc community, many reports
have described transcription factor binding in hESCs and other
developmental cell types (Boyer et al., 2005; Cole et al., 2008;
Fujiwara et al., 2009; Yu et al., 2009). To date, our datasets are unique,
representing not just a single transcription factor, but a complex of
factors. Furthermore, these datasets follow the dynamics of this
complex of transcription factors through developmental time — from
hESC pluripotency to the transformation of hESC into endoderm. An in
depth analysis of the relationship between the datasets for SMAD2/3,
SMAD3, SMAD4, FOXH1, H3K4me3 and H3K27me3 provides insight
into mechanisms underlying how SMAD transcription factors mediate
Nodal signaling to specify endoderm. One of the surprising ﬁndings
from this study is that SMAD2/3, SMAD3 and SMAD4 binding is highly
dynamic; few speciﬁc bound regions are maintained from hESCs to
endoderm. This suggests that the SMAD transcription complex is
constantly in ﬂux, using a variety of different sites to elicit activation
of individual loci. Furthermore, we also show that FOXH1 has very
different binding behavior than the SMAD proteins. First, throughout
differentiation, FOXH1 maintains association with the same general
genomic locations, whereas SMAD proteins become far more localized
in intergenic regions once cells have become endoderm. Second, upon
differentiation FOXH1 exhibits widespread binding throughout the
genome whereas the SMADs become far more restricted to speciﬁc
locales. This is consistent with a role of FOXH1, not speciﬁcally as a
transcriptional activator, but as a pioneer protein which associates
with chromatin to recruit histone modiﬁers to these loci (Cirillo et al.,
2002; Cirillo and Zaret, 1999).
Nodal signaling is reused throughout development to guide the
formation of a plethora of tissue types. It has also been implicated in
several cancers (Gupta et al., 2004; Lee et al., 2010; Mangone et al.,
2010; Xu et al., 2004). Despite the importance of this signaling
pathway, few direct targets have been elucidated since the SMAD
transcription factors were identiﬁed more than 15 years ago. Here we
provide a toolbox for the regions bound by the transcription factors
SMAD2/3, SMAD3, SMAD4 and FOXH1 and the histone modiﬁcations
H3K4me3 and H3K27me3 in both hESCs and derived endoderm that
can be used for the functional examination of thousands of additional
targets. These targets, several of which are bound by the SMAD
complex in both hESCs and derived endoderm, may also be bound and
activated in a multitude of other normal and diseased cell types. Thus,
we anticipate that the analysis of these factors will have wide-spread
beneﬁt to the scientiﬁc community by providing both thousands of
SMAD targets for further analysis and genomic data that can continually
be mined.
Supplementarymaterials related to this article can be found online
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